Apr 01, 2022 Issue
Patient Education Interventions Improve A1C Values [FPIN's Clinical Inquiries]

Patient education interventions, specifically those including face-to-face interactions with trained educators or nurses, improve A1C values in patients by 0.3% to 1.4% compared with usual diabetes care.

Apr 01, 2022 Issue
Prevention or Delay of Type 2 Diabetes Mellitus: Recommendations From the American Diabetes Association [Practice Guidelines]

The American Diabetes Association (ADA) has released updated guidelines for the prevention or delay of diabetes.

Mar 01, 2022 Issue
Telemedicine in Diabetes Care [Article]

Telemedicine can be useful for the management of diabetes mellitus. Remote monitoring of glucose levels improves A1C levels in people with poor glucose control. When multiple daily injections of insulin are required, continuous glucose monitoring improves glycemic control and increases patient satis...

Feb 01, 2022 Issue
Maturity-Onset Diabetes of the Young: Rapid Evidence Review [Article]

Maturity-onset diabetes of the young (MODY) is a non–insulin-dependent form of diabetes mellitus that is usually diagnosed in young adulthood. MODY is most often an autosomal dominant disease and is divided into subtypes (MODY1 to MODY14) based on the causative genetic mutation. Subtypes 1 to 3 acco...

Jan 01, 2022 Issue
Guidelines for When to Consider Mortality-Reducing Treatments for Patients With Type 2 Diabetes Mellitus [POEMs]

The guidelines give clear guidance on selecting an SGLT2 inhibitor, a GLP-1 receptor agonist, or neither in patients with type 2 diabetes. The guidelines are a bit conservative to some, but guideline development is a two-step process: determining the evidence and then weighing the value based on benefits and risks.

Jan 01, 2022 Issue
Screening for Prediabetes and Type 2 Diabetes [U.S. Preventive Services Task Force]

The USPSTF recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity. Clinicians should offer or refer patients with prediabetes to effective preventive interventions.

Jan 01, 2022 Issue
Screening for Prediabetes and Type 2 Diabetes Mellitus [Putting Prevention into Practice]

A 36-year-old, D.P., presents to your clinic as a new patient for a wellness visit. D.P. has no current health concerns but states that they had gestational diabetes during their last pregnancy three years ago. The patient reports that their father has diabetes mellitus and takes insulin. D.P.'s bod...

Dec 01, 2021 Issue
Prediabetes Diagnosis: Helpful or Harmful? [Lown Right Care: Reducing Overuse and Underuse]

A collaboration between AFP and the Lown Institute promotes a vision of delivering health care that is based on the evidence, balanced in its approach, and focused on the patient.

Oct 01, 2021 Issue
For Patients with Type 2 Diabetes Mellitus Who Are Taking a GLP-1 Receptor Agonist, an SGLT2 Inhibitor May Be Preferred to a Sulfonylurea as Add-on Therapy [POEMs]

This propensity score–matched analysis (not funded by industry) concluded that an SGLT2 inhibitor is preferred over a sulfonylurea for patients with type 2 diabetes who are already taking a GLP-1 receptor agonist, with favorable effects on the likelihood of hospitalization for myocardial infarction and heart failure, and all-cause mortality.

Oct 01, 2021 Issue
Diabetes-Related Foot Infections: Diagnosis and Treatment [Article]

Diabetes-related foot infections occur in approximately 40% of diabetes-related foot ulcers and cause significant morbidity. Clinicians should consider patient risk factors (e.g., presence of foot ulcers greater than 2 cm, uncontrolled diabetes mellitus, poor vascular perfusion, comorbid illness) wh...

Pages: 1 2 3 4 5 6 7 8 9 10 ... 20 Next

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now